Skip to content
healthcare.dev

Lamotrigine

NDC 68462-229, Lamotrigine, tablet, chewable, from Glenmark Pharmaceuticals Inc., USA.

Product NDC
68462-229
Status
Listed
Labeler
Glenmark Pharmaceuticals Inc., USA
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA079099
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68462-229 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMOTRIGINE25 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
68462-229-0168462022901100 TABLET, CHEWABLE in 1 BOTTLE (68462-229-01)
68462-229-10684620229101000 TABLET, CHEWABLE in 1 BOTTLE (68462-229-10)
68462-229-906846202299090 TABLET, CHEWABLE in 1 BOTTLE (68462-229-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/50fcf452-2d21-493e-a1dd-0c6ea9ac6184
  • NADAC price for package 68462022901

    GET /v1/drugs/nadac/68462022901

Use it

Look up 68462-229 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68462-229 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68462-229. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.